Prospective analysis on the outcomes of histotripsy for primary and metastatic liver tumors
Histotripsy was a safe and effective non-invasive treatment for liver tumors, demonstrating promising clinical outcomes and systemic immune activation. These findings supported further investigation into its long-term efficacy and potential synergy with immunotherapy.
Authors
- Albert Chan (ORCID: https://orcid.org/0000-0002-1383-2952)
- Huanhuan Ma (ORCID: https://orcid.org/0000-0001-8029-6814)
- Irene Oi‐Lin Ng (ORCID: https://orcid.org/0000-0001-7532-2029)
- Abdullah Husain (ORCID: https://orcid.org/0000-0003-0004-9974)
- Gordon Wong
- YW Chan
- L.C.K. Ng
- Kwan Man
- Vince Lau
Institutions
- Chinese University of Hong Kong (HK)
- Queen Mary Hospital (CN)
- Gleneagles Hospital (SG)
- State Key Laboratory of Synthetic Chemistry (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1097/js9.0000000000003856
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00